Defective interfering viruses and their impact on vaccines and viral vectors

被引:51
|
作者
Frensing, Timo [1 ,2 ]
机构
[1] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, D-39106 Magdeburg, Germany
[2] Otto Von Guericke Univ, Cellular Syst Bioproc Engn, Magdeburg, Germany
关键词
Defective interfering particles; Influenza virus; Viral vaccines; Viral vectors; Virus production; SEMLIKI-FOREST-VIRUS; INFLUENZA-VIRUS; MEASLES-VIRUS; WILD-TYPE; IN-VIVO; VESICULAR STOMATITIS; GENE-EXPRESSION; INFECTED-CELLS; T-PARTICLES; DI RNAS;
D O I
10.1002/biot.201400429
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Defective interfering particles (DIPs) have been found for many important viral pathogens and it is believed that most viruses generate DIPs. This article reviews the current knowledge of the generation and amplification of DIPs, which possess deletions in the viral genome but retain the ability to replicate in the presence of a complete helper virus. In addition, mechanisms are discussed by which DIPs interfere with the replication of their helper virus leading to the production of mainly progeny DIPs by coinfected cells. Even though DIPs cannot replicate on their own, they are biologically active and it is well known that they have a huge impact on virus replication, evolution, and pathogenesis. Moreover, defective genomes are potent inducers of the innate immune response. Yet, little attention has been paid to DIPs in recent years and their impact on biotechnological products such as vaccines and viral vectors remains elusive in most cases. With a focus on influenza virus, this review demonstrates that DIPs are important for basic research on viruses and for the production of viral vaccines and vectors. Reducing the generation and/or amplification of DIPs ensures reproducible results as well as high yields and consistent product quality in virus production.
引用
收藏
页码:681 / U56
页数:11
相关论文
共 50 条
  • [21] Downstream processing of viral vectors and vaccines
    R Morenweiser
    Gene Therapy, 2005, 12 : S103 - S110
  • [22] Recombinant viral vectors: Cancer vaccines
    Harrop, Richard
    John, Justin
    Carroll, Miles W.
    ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (08) : 931 - 947
  • [23] Ensuring. Viral Safety of Viral Vaccines and Vectors
    Boumlic, Anissa
    Wisher, Martin
    Asher, Damon
    Pattnaik, Priyabrata
    BIOPHARM INTERNATIONAL, 2018, 31 (09) : 36 - 42
  • [24] EFFECTS OF VIRUSES AND VIRAL VACCINES ON CNS
    DAYAN, AD
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1975, 68 (09): : 562 - 562
  • [25] Defective Interfering Viral Particles in Acute Dengue Infections
    Li, Dongsheng
    Lott, William B.
    Lowry, Kym
    Jones, Anita
    Thu, Hlaing Myat
    Aaskov, John
    PLOS ONE, 2011, 6 (04):
  • [26] Defective Interfering Particles of Negative-Strand RNA Viruses
    Ziegler, Christopher M.
    Botten, Jason W.
    TRENDS IN MICROBIOLOGY, 2020, 28 (07) : 554 - 565
  • [28] Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence
    Manzoni, Tomaz B.
    Lopez, Carolina B.
    FUTURE VIROLOGY, 2018, 13 (07) : 493 - 503
  • [29] Defective and defective interfering RNAs of monopartite plus-strand RNA plant viruses
    White, KA
    Morris, TJ
    SATELLITES AND DEFECTIVE VIRAL RNAS, 1999, 239 : 1 - 17
  • [30] Plasmid vectors as anti-viral vaccines
    Ertl, HCJ
    Verma, P
    He, Z
    Xiang, ZQ
    DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 77 - 87